Seeking Alpha

Stryker (SYK) signs a definitive agreement to acquire orthobiologic and biosurgery product maker...

Stryker (SYK) signs a definitive agreement to acquire orthobiologic and biosurgery product maker Orthovita (VITA) for ~$304M in cash. Shareholders will receive $3.85/share, a 41% premium over Friday's close. The deal also includes $12M in debt. VITA +40.3% premarket. (PR)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs